World’s first CRISPR Clinical trial has just been Approved!

22/06/2016 - 3 minutes

CRISPR has received a regulatory green light in what could be the first clinical trial with the “scientific discovery of the century”. It’ll be used to improve cancer cell therapies.

crispr_logo_grayCRISPR has already revolutionized biotech, quickly overtaking the field of gene editing. It also has immense potential in the therapeutic field, so it’s not surprising there’s a lot of interest, not to mention its famous patent war.

What may be surprising is the amount of money involved, with $120M mega-rounds by Editas Medicine (US), plus $70M for Intellia (US) and €79.5M for CRISPR Therapeutics (Switzerland). That’s a lot of money for something without any clinical data! ( a topic brought up during the CRISPR fireside chat at Refresh…)

This clinical data is now one step closer to reality as the US National Institutes of Health (NIH) approved a study proposal to use CRISPR/Cas9 technology to improve cancer cell therapies. While it still needs FDA approval,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

You might also be interested in the following:

Support Us

Become a Member